Neyman Seminar - Risk perception and decision-making in the context of cancer treatment using genomic tests
Feb 27, 2013, 04:00 PM - 05:00 PM | 1011 Evans Hall | Happening As Scheduled
Julia Brettschneider, Department of Statistics, University of Warwick (Speaker)
Genomic information is used to guide decisions about cancer treatment and (recurrence) prophylaxis. All these test results come with uncertainty, some with a high degree. Shared decision-making by physicians and patients makes perceived risks and attitudes towards the involved tests relevant for the decision processes and outcomes. Discrepancies between human intuitions and normative rules...